Home About us Editorial board Ahead of print Browse Articles Search Submit article Instructions Subscribe Contacts Login 
  • Users Online: 375
  • Home
  • Print this page
  • Email this page

    Article Cited by others

REVIEW ARTICLE

Alpha-synuclein structure, functions, and interactions

Emamzadeh Fatemeh Nouri

Year : 2016| Volume: 21| Issue : 1 | Page no: 29-29

   This article has been cited by
 
1 a-synuclein-lipoprotein interactions and elevated ApoE level in cerebrospinal fluid from Parkinsonæs disease patients
Wojciech Paslawski,Justyna Zareba-Paslawska,Xiaoqun Zhang,Katharina Hölzl,Henrik Wadensten,Mohammadreza Shariatgorji,Shorena Janelidze,Oskar Hansson,Lars Forsgren,Per E. Andrén,Per Svenningsson
Proceedings of the National Academy of Sciences. 2019; : 201821409
[Pubmed]  [Google Scholar] [DOI]
2 Recent advances of induced pluripotent stem cells application in neurodegenerative diseases
Nashwa Amin,Xiaoning Tan,Qiannan Ren,Ning Zhu,Benson O.A. Botchway,Zhiying Hu,Marong Fang
Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2019; 95: 109674
[Pubmed]  [Google Scholar] [DOI]
3 Mechanical and thermodynamic properties of Aß42, Aß40, and a-synuclein fibrils: a coarse-grained method to complement experimental studies
Adolfo B Poma,Horacio V Guzman,Mai Suan Li,Panagiotis E Theodorakis
Beilstein Journal of Nanotechnology. 2019; 10: 500
[Pubmed]  [Google Scholar] [DOI]
4 The Role of Aptamer Loaded Exosome Complexes in the Neurodegenerative Diseases
Simranjeet Singh Sekhon,Gna Ahn,Ga-Young Park,Dae-Young Park,Sang-Hee Lee,Ji-Young Ahn,Yang-Hoon Kim
Toxicology and Environmental Health Sciences. 2019; 11(2): 85
[Pubmed]  [Google Scholar] [DOI]
5 Implications of alpha-synuclein nitration at tyrosine 39 in methamphetamine-induced neurotoxicity in vitro and in vivo
Hong-Hua Qiao,Lin-Nan Zhu,Yue Wang,Jia-Liang Hui,Wei-Bing Xie,Chao Liu,Ling Chen,Ping-Ming Qiu
Neural Regeneration Research. 2019; 14(2): 319
[Pubmed]  [Google Scholar] [DOI]
6 Novel Immunotherapeutic Approaches to Target Alpha-Synuclein and Related Neuroinflammation in Parkinson’s Disease
Maria Zella,Judith Metzdorf,Friederike Ostendorf,Fabian Maass,Siegfried Muhlack,Ralf Gold,Aiden Haghikia,Lars Tönges
Cells. 2019; 8(2): 105
[Pubmed]  [Google Scholar] [DOI]
7 Lipids at the Crossroad of a-Synuclein Function and Dysfunction: Biological and Pathological Implications
Natalia P. Alza,Pablo A. Iglesias González,Melisa A. Conde,Romina M. Uranga,Gabriela A. Salvador
Frontiers in Cellular Neuroscience. 2019; 13
[Pubmed]  [Google Scholar] [DOI]
8 Prion Efficiently Replicates in a-Synuclein Knockout Mice
Edoardo Bistaffa,Martina Rossi,Chiara Maria Giulia De Luca,Federico Cazzaniga,Olga Carletta,Ilaria Campagnani,Fabrizio Tagliavini,Giuseppe Legname,Giorgio Giaccone,Fabio Moda
Molecular Neurobiology. 2019;
[Pubmed]  [Google Scholar] [DOI]
9 Reprint of “Ganglioside lipids accelerate a-synuclein amyloid formation”
Ricardo Gaspar,Jon Pallbo,Ulrich Weininger,Sara Linse,Emma Sparr
Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 2019;
[Pubmed]  [Google Scholar] [DOI]
10 Plasma a -synuclein levels are increased in patients with obstructive sleep apnea syndrome
Hao-Lun Sun,Bin-Lu Sun,Dong-Wan Chen,Yang Chen,Wei-Wei Li,Man-Yu Xu,Ying-Ying Shen,Zhi-Qiang Xu,Yan-Jiang Wang,Xian-Le Bu
Annals of Clinical and Translational Neurology. 2019;
[Pubmed]  [Google Scholar] [DOI]
11 Prion and Prion-Like Protein Strains: Deciphering the Molecular Basis of Heterogeneity in Neurodegeneration
Carlo Scialò,Elena De Cecco,Paolo Manganotti,Giuseppe Legname
Viruses. 2019; 11(3): 261
[Pubmed]  [Google Scholar] [DOI]
12 In-vitro and in-silico investigation of protective mechanisms of crocin against E46K a-synuclein amyloid formation
Marzieh Ghasemi Tigan,Arezou Ghahghaei,Milad Lagzian
Molecular Biology Reports. 2019;
[Pubmed]  [Google Scholar] [DOI]
13 Selective vulnerability in a-synucleinopathies
Javier Alegre-Abarrategui,Katherine R. Brimblecombe,Rosalind F. Roberts,Elisavet Velentza-Almpani,Bension S. Tilley,Nora Bengoa-Vergniory,Christos Proukakis
Acta Neuropathologica. 2019;
[Pubmed]  [Google Scholar] [DOI]
14 A Coarse-Grained Molecular Dynamics Approach to the Study of the Intrinsically Disordered Protein a-Synuclein
Rafael Ramis,Joaquín Ortega-Castro,Rodrigo Casasnovas,Laura Mariño,Bartolomé Vilanova,Miquel Adrover,Juan Frau
Journal of Chemical Information and Modeling. 2019; 59(4): 1458
[Pubmed]  [Google Scholar] [DOI]
15 Mass Spectrometric Analysis of Lewy Body-Enriched a-Synuclein in Parkinson’s Disease
Payel Bhattacharjee,Annika Öhrfelt,Tammaryn Lashley,Kaj Blennow,Ann Brinkmalm,Henrik Zetterberg
Journal of Proteome Research. 2019;
[Pubmed]  [Google Scholar] [DOI]
16 Insights into the Molecular Mechanisms of Alzheimer’s and Parkinson’s Diseases with Molecular Simulations: Understanding the Roles of Artificial and Pathological Missense Mutations in Intrinsically Disordered Proteins Related to Pathology
Orkid Coskuner-Weber,Vladimir Uversky
International Journal of Molecular Sciences. 2018; 19(2): 336
[Pubmed]  [Google Scholar] [DOI]
17 Clearing Extracellular Alpha-Synuclein from Cerebrospinal Fluid: A New Therapeutic Strategy in Parkinson’s Disease
Manuel Menéndez-González,Huber Padilla-Zambrano,Cristina Tomás-Zapico,Benjamin García
Brain Sciences. 2018; 8(4): 52
[Pubmed]  [Google Scholar] [DOI]
18 Salt-bridge dynamics in intrinsically disordered proteins: A trade-off between electrostatic interactions and structural flexibility
Sankar Basu,Parbati Biswas
Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 2018; 1866(5-6): 624
[Pubmed]  [Google Scholar] [DOI]
19 Cellular Proteostasis in Neurodegeneration
Alberim Kurtishi,Benjamin Rosen,Ketan S. Patil,Guido W. Alves,Simon G. Møller
Molecular Neurobiology. 2018;
[Pubmed]  [Google Scholar] [DOI]
20 Parkinson’s Disease: Biomarkers, Treatment, and Risk Factors
Fatemeh N. Emamzadeh,Andrei Surguchov
Frontiers in Neuroscience. 2018; 12
[Pubmed]  [Google Scholar] [DOI]
21 Crucial role of protein oligomerization in the pathogenesis of Alzheimeræs and Parkinsonæs diseases
Minee L. Choi,Sonia Gandhi
The FEBS Journal. 2018;
[Pubmed]  [Google Scholar] [DOI]
22 Using Patient-Derived Induced Pluripotent Stem Cells to Identify Parkinson’s Disease-Relevant Phenotypes
S. L. Sison,S. C. Vermilyea,M. E. Emborg,A. D. Ebert
Current Neurology and Neuroscience Reports. 2018; 18(12)
[Pubmed]  [Google Scholar] [DOI]
23 Recent progress of drug nanoformulations targeting to brain
Abdur Rauf Khan,Xiaoye Yang,Manfei Fu,Guangxi Zhai
Journal of Controlled Release. 2018;
[Pubmed]  [Google Scholar] [DOI]
24 Formation of Heterotypic Amyloids: a-Synuclein in Co-Aggregation
Karishma Bhasne,Samrat Mukhopadhyay
PROTEOMICS. 2018; : 1800059
[Pubmed]  [Google Scholar] [DOI]
25 The role of posttranslational modifications of a-synuclein and LRRK2 in Parkinsonæs disease: Potential contributions of environmental factors
Edward Pajarillo,Asha Rizor,Jayden Lee,Michael Aschner,Eunsook Lee
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2018;
[Pubmed]  [Google Scholar] [DOI]
26 The Cellular Environment Affects Monomeric a-Synuclein Structure
Amberley D. Stephens,Maria Zacharopoulou,Gabriele S. Kaminski Schierle
Trends in Biochemical Sciences. 2018;
[Pubmed]  [Google Scholar] [DOI]
27 Alpha-synuclein mitochondrial interaction leads to irreversible translocation and complex I impairment
Jimena H. Martínez,Federico Fuentes,Virginia Vanasco,Silvia Alvarez,Agustina Alaimo,Adriana Cassina,Federico Coluccio Leskow,Francisco Velazquez
Archives of Biochemistry and Biophysics. 2018; 651: 1
[Pubmed]  [Google Scholar] [DOI]
28 Comparing the Folds of Prions and Other Pathogenic Amyloids
José Flores-Fernández,Vineet Rathod,Holger Wille
Pathogens. 2018; 7(2): 50
[Pubmed]  [Google Scholar] [DOI]
29 Effect of rs3910105 in the Synuclein Gene on Dopamine Transporter Availability in Healthy Subjects
Youngduk Seo,Kyoungjune Pak,Hyun-Yeol Nam,Ju Won Seok,Myung Jun Lee,Eun-Joo Kim,Jae Meen Lee,Seong Jang Kim,In Joo Kim
Yonsei Medical Journal. 2018; 59(6): 787
[Pubmed]  [Google Scholar] [DOI]
30 Alpha-Synuclein Toxicity on Protein Quality Control, Mitochondria and Endoplasmic Reticulum
Thaiany Quevedo Melo,Sjef J. C. V. M. Copray,Merari F. R. Ferrari
Neurochemical Research. 2018;
[Pubmed]  [Google Scholar] [DOI]
31 Post-translational modifications of Parkinsonæs disease-related proteins: Phosphorylation, SUMOylation and ubiquitination
Stella C. Junqueira,Eduarda G.Z. Centeno,Kevin A. Wilkinson,Helena Cimarosti
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2018;
[Pubmed]  [Google Scholar] [DOI]
32 Ganglioside lipids accelerate a-synuclein amyloid formation
Ricardo Gaspar,Jon Pallbo,Ulrich Weininger,Sara Linse,Emma Sparr
Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 2018; 1866(10): 1062
[Pubmed]  [Google Scholar] [DOI]
33 Familial Mutations May Switch Conformational Preferences in a-Synuclein Fibrils
Liang Xu,Buyong Ma,Ruth Nussinov,Damien Thompson
ACS Chemical Neuroscience. 2017;
[Pubmed]  [Google Scholar] [DOI]
34 Ginkgolide K promotes the clearance of A53T mutation alpha-synuclein in SH-SY5Y cells
Wenbo Yu,Sheng Chen,Liang Cao,Jie Tang,Wei Xiao,Baoguo Xiao
Cell Biology and Toxicology. 2017;
[Pubmed]  [Google Scholar] [DOI]
35 Bone loss in C57BL/6J-OlaHsd mice, a substrain of C57BL/6J carrying mutated alpha-synuclein and multimerin-1 genes
Tamar Liron,Bitya Raphael,Sahar Hiram-Bab,Itai A. Bab,Yankel Gabet
Journal of Cellular Physiology. 2017;
[Pubmed]  [Google Scholar] [DOI]
36 a-Synuclein aggregation modulation: an emerging approach for the treatment of Parkinsonæs disease
Sushil K Singh,Aloke Dutta,Gyan Modi
Future Medicinal Chemistry. 2017; 9(10): 1039
[Pubmed]  [Google Scholar] [DOI]
37 Small molecule probes of protein aggregation
Lydia M Young,Alison E Ashcroft,Sheena E Radford
Current Opinion in Chemical Biology. 2017; 39: 90
[Pubmed]  [Google Scholar] [DOI]
38 DT-diaphorase Protects Against Autophagy Induced by Aminochrome-Dependent Alpha-Synuclein Oligomers
Patricia S. Muñoz,Juan Segura-Aguilar
Neurotoxicity Research. 2017;
[Pubmed]  [Google Scholar] [DOI]
39 iPS cells in the study of PD molecular pathogenesis
Melanie M. Cobb,Abinaya Ravisankar,Gaia Skibinski,Steven Finkbeiner
Cell and Tissue Research. 2017;
[Pubmed]  [Google Scholar] [DOI]
40 Up-regulation of autophagy-related gene 5 (ATG5) protects dopaminergic neurons in a zebrafish model of Parkinsonæs disease
Zhan-ying Hu,Bo Chen,Jing-pu Zhang,Yuan-yuan Ma
Journal of Biological Chemistry. 2017; 292(44): 18062
[Pubmed]  [Google Scholar] [DOI]
41 Synucleins and Gene Expression: Ramblers in a Crowd or Cops Regulating Traffic?
Alexei A. Surguchev,Andrei Surguchov
Frontiers in Molecular Neuroscience. 2017; 10
[Pubmed]  [Google Scholar] [DOI]
42 Role of Apolipoproteins and a-Synuclein in Parkinson’s Disease
Fatemeh Nouri Emamzadeh
Journal of Molecular Neuroscience. 2017;
[Pubmed]  [Google Scholar] [DOI]
43 Finding a new purpose for old drugs
Evan Y. Snyder
Science. 2017; 357(6354): 869
[Pubmed]  [Google Scholar] [DOI]
44 Correlation of Plasma EGF with Striatal Dopamine Transporter Availability in Healthy Subjects
Kyoungjune Pak,Seunghyeon Shin,So Jung Kim,Keunyoung Kim,Bum Soo Kim,Seong Jang Kim,In Joo Kim
Scientific Reports. 2017; 7(1)
[Pubmed]  [Google Scholar] [DOI]

 

Read this article